Form 4: Thermo Fisher Scientific Director Scott M. Sperling Reports Acquisition of Phantom Stock Units

Director Scott M. Sperling reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Summary

• Scott M. Sperling, a director of Thermo Fisher Scientific, reported the acquisition of phantom stock units.
• The transaction occurred on March 29, 2025.
• Sperling acquired 82.47 phantom stock units at a price of $500.16 per unit.
• These units are convertible into common stock on a 1-for-1 basis.
• The acquisition was made pursuant to the Issuer's Deferred Compensation Plan for Directors.
• Following the transaction, Sperling beneficially owns 17,234.77 phantom stock units.
• The shares are distributable as stock upon cessation of director service or a change of control.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a routine transaction related to director compensation. It doesn't inherently indicate positive or negative performance for the company.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.
• The Deferred Compensation Plan for Directors aligns the interests of directors with those of shareholders.

Future Outlook

The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Industry Context

Director stock acquisitions are common in publicly traded companies as part of compensation packages and are often seen as a sign of management's confidence in the company's prospects. This filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder sentiment, reflecting confidence in the company's future.

Key Dates

Keywords

Thermo Fisher Scientific, Scott M. Sperling, phantom stock units, director, Form 4, deferred compensation plan, TMO